ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.625
-0.03%
Brent Oil
76.495
0.00%
Bitcoin
98,512.66
0.31%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Smith & Nephew Plc (SN.) Cotización

Smith & Nephew Plc

Smith & Nephew Plc (SN.)

LSE
980.80
-12.40
(-1.25%)
Cerrado 05 Enero 10:30AM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
980.80
Postura de Compra
983.00
Postura de Venta
983.40
Volume Operado de la Acción
1,513,584
978.20 Rango del Día 989.60
911.00 Rango de 52 semanas 1,244.50
Capitalización de Mercado [m]
8.576B
Precio Anterior
993.20
Precio de Apertura
981.60
Hora
24
@
980.8
(O)
Última hora de negociación
Volumen financiero
14,876,896p
Precio Promedio Ponderado
982.892
Volumen promedio (3 m)
2,740,851
Acciones en circulación
874,374,111
Rendimiento del Dividendo
4.75%
Ratio Precio/Utilidad
32.68
Beneficio por acción (BPA)
0.3
turnover
5.55B
Beneficio neto
263M

Acerca de Smith & Nephew Plc

Sector
Ortho,prosth,surg Appl,suply
Industria
Ortho,prosth,surg Appl,suply
Sede
Watford, Gbr
Fundado
1937
Smith & Nephew Plc is listed in the Ortho,prosth,surg Appl,suply sector of the London Stock Exchange with ticker SN.. The last closing price for Smith & Nephew was 993.20p. Over the last year, Smith & Nephew shares have traded in a share price range of 911.00p to 1,244.50p.

Smith & Nephew currently has 874,374,111 shares in issue. The market capitalisation of Smith & Nephew is £8.68 billion. Smith & Nephew has a price to earnings ratio (PE ratio) of 32.68.

SN. Últimas noticias

Más noticias

Smith & Nephew Plc Total Voting Rights

Smith & Nephew Plc 02 January 2025   2 January 2025   Voting Rights and Capital       In conformity with Rule 5.6 of the FCA's Disclosure and Transparency Rules:-   The total issued share...

02 Enero 2025
RNS Regulatory News

Smith & Nephew Plc Director/PDMR Shareholding

Smith & Nephew Plc 20 December 2024     SMITH & NEPHEW PLC   20 December 2024   NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE MARKET ABUSE REGULATION OF...

20 Diciembre 2024
RNS Regulatory News

Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty

Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty Latest expansion to the CORI◊ Surgical System portfolio provides a personalized solution for...

19 Diciembre 2024
UK Regulatory

Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty

Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it...

16 Diciembre 2024
UK Regulatory

Smith & Nephew Plc Holding(s) in Company

Smith & Nephew Plc 16 December 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0009223206 Issuer Name SMITH & NEPHEW PLC UK or Non-UK Issuer UK...

16 Diciembre 2024
RNS Regulatory News

Smith & Nephew Plc Holding(s) in Company

Smith & Nephew Plc 12 December 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0009223206 Issuer Name SMITH & NEPHEW PLC UK or Non-UK Issuer UK...

12 Diciembre 2024
RNS Regulatory News

Smith & Nephew Plc Holding(s) in Company

Smith & Nephew Plc 11 December 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0009223206 Issuer Name SMITH & NEPHEW PLC UK or Non-UK Issuer UK...

11 Diciembre 2024
RNS Regulatory News

Smith & Nephew Plc Director/PDMR Shareholding

Smith & Nephew Plc 09 December 2024     SMITH & NEPHEW PLC   9 December 2024   NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE MARKET ABUSE REGULATION OF...

09 Diciembre 2024
RNS Regulatory News

Smith & Nephew Plc Director Share Award vest and sale to cover tax

Smith & Nephew Plc 06 December 2024     SMITH & NEPHEW PLC   6 December 2024   NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION...

06 Diciembre 2024
RNS Regulatory News

Smith & Nephew Plc Holding(s) in Company

Smith & Nephew Plc 05 December 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0009223206 Issuer Name SMITH & NEPHEW PLC UK or Non-UK Issuer UK...

05 Diciembre 2024
RNS Regulatory News
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
14.40.450634985662976.41002.5976.41327323988.29841438DE
44.80.4918032786899761002.5961.82073666984.59864564DE
12-108.7-9.977053694361089.5113691127408511006.58835861DE
263.40.347861673829977.41244.591125540231076.30547816DE
52-80.2-7.558906691810611244.591128050921053.17157173DE
156-335.7-25.49943030761316.51357.588727769911107.06847712DE
260-858.7-46.68116335961839.5202388725919341242.64022259DE

SN. - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Smith & Nephew?
El precio actual de las acciones de Smith & Nephew es 980.80p
¿Cuántas acciones de Smith & Nephew están en circulación?
Smith & Nephew tiene 874,374,111 acciones en circulación
¿Cuál es la capitalización de mercado de Smith & Nephew?
La capitalización de mercado de Smith & Nephew es GBP 8.68B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Smith & Nephew?
Smith & Nephew ha negociado en un rango de 911.00p a 1,244.50p durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Smith & Nephew?
El ratio precio/beneficio de Smith & Nephew es 32.68
¿Cuál es el ratio de efectivo a ventas de Smith & Nephew?
El ratio de efectivo a ventas de Smith & Nephew es 1.55
¿Cuál es la moneda de reporte de Smith & Nephew?
Smith & Nephew presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Smith & Nephew?
El último ingresos anual de Smith & Nephew es USD 5.55B
¿Cuál es el último beneficio anual de Smith & Nephew?
El último beneficio anual de Smith & Nephew es USD 263M
¿Cuál es la dirección registrada de Smith & Nephew?
La dirección registrada de Smith & Nephew es BUILDING 5, CROXLEY PARK, HATTERS LANE, HERTFORDSHIRE, WATFORD, WD18 8YE
¿En qué sector industrial opera Smith & Nephew?
Smith & Nephew opera en el sector ORTHO,PROSTH,SURG APPL,SUPLY

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discusión

Ver feed completo
Jahvik Jahvik 4 minutos hace
Really?
Is that all that you read?
Keep trying 
HMBL
lizzy241 lizzy241 4 minutos hace
Mr Stockboy, the company stated a few months ago that the buyback would be put on hold until further notice.
AMRN
JR30 JR30 5 minutos hace
"Scummy way of sticking your finger in the eyes of those whose retirement plans got wiped out…    That makes you feel good?"

Not as scummy as shorty and those that supposedly got their retirement plans wiped out trying to make the value of their investment go down by posting negative
VERB
Glycobio Glycobio 6 minutos hace
Your quote does not refute or cancel out the conclusion from Dr. Chalasani, who is looking at all the data in great detail (more than what we have access to). His conclusion of reproducible benefit is a strong statement for significant value of belapectin in cirrhosis.

Not sure why y
GALT
capgain capgain 6 minutos hace
It's not supposed to stop snowing there until midnight tomorrow night, according to my weather. It's going to be a big one.
Hoskuld Hoskuld 8 minutos hace
It is good that you pointed out that the trials were in Australia, Canada, UK, Germany, and the Netherlands and the duration was 48 weeks per protocol. Also good that you pointed out that the 58 fully accredited authors independently wrote the paper and analyzed the data. The next 2 weeks should b
AVXL
Top Penny Top Penny 8 minutos hace
https://x.com/TruestoneL52236
PSRU
pantherj pantherj 8 minutos hace
As usual, you try to change the subject because you cannot deal with the facts.
IFUS
Gnewton14 Gnewton14 9 minutos hace
Optimistic speculation it's all connected. 8 days to launch with SpaceX and there's a $1.5 billion defense announcement? Now that'd be something 
LAES
Tr8dervic Tr8dervic 9 minutos hace
Powerball Winning Numbers
Sat, Jan 4, 2025
26
32
43
54
56
24
Power Play
2x
Estimated Jackpot: $206 Million
Cash Value: $92.1 Million

Next Drawing
Mon, Jan 6, 2025
Estimated Jackpot
$220
100lbStriper 100lbStriper 9 minutos hace
lol!!! thats not funny, it may actually happen!!! man its been an eternity since i've heard that!!!
NLST
Homebrew Homebrew 10 minutos hace
Wow...Guerguerian's a real scumbag. He posted on Linked in to sucker newbies into his gambling scheme.
ERHE
ducci1 ducci1 10 minutos hace
Roger That! Fun Sharing What others Have Shared With Me Over The Years !! ( Also Keeps My Old Brain Excercised !! )
SPY
vdog1776 vdog1776 10 minutos hace
Yeah, we all don’t read. I know everything’s bad everything’s negative! So why are you here again then?
VXIT
sunspotter sunspotter 10 minutos hace
There’s every reason to believe IPIX no longer has any stake in BeaMed, and literally no logical reason to believe otherwise.
IPIX
IH Admin [Shelly] IH Admin [Shelly] 12 minutos hace
Alright, folks, you need to get back to talking about AZRH without all the attacks. There are quite a few of who are a deletion or two away from restrictions, so please heed this warning.

Mods, you should be removing posts like these, not responding in kind.
AZRH
camelion camelion 12 minutos hace
If you bring this info up via X in a direct message to the company. then you might get productive responses instead with the other.
HIRU
prototype_101 prototype_101 12 minutos hace
teddybear said, I’m so honored by your post and by how many people agreed with you

Ok teddybear, so since you love Dreamtravbelgium's post celebrating YOU so much, how about making a public recommendation to replace your current Yellow Sticky post #20676&
ASM LWLG
sunspotter sunspotter 12 minutos hace
Actually this quote sums up the whole situation perfectly:

“ While there was a favorable trend for incidence of varices in the primary end point intent-to-treat population, belapectin did not achieve statistical significance”

And not only do I understand pharmaceutical
GALT
Atown62 Atown62 13 minutos hace
Nobody is more entertained then you Imafan when the ceo is dressing up, or visiting your coffee shop
HHSE
nowwhat2 nowwhat2 14 minutos hace
Hang in there XPArmy......Don't let the fear mongerers drive nails into your head.
Just smash the Moe Like Button instead.


https://www.youtube.com/watch?v=D5oX1D8t6Ng





We are number one in XRP Army Land !

XRPUSD
Iggy_Bot Iggy_Bot 14 minutos hace
For sure a couple more cycles and most will probably be gone
Slow waiter Slow waiter 15 minutos hace
Slow waiter has been waiting a long time.
Now, I want to hear news of progress. I would like to hear news soon. This no news business is not far to us long timers.
TMMI
Smattchew Smattchew 15 minutos hace
"Some of you guys" also includes yourself, mcbot. Six or whatever many years it has been now, and not a lick of abandonment. Have a great Sunday, and enjoy this conversation about fka $bioaq it's the same one you've had forever and forever. It's impressive how much you care about a dead company!
BIOAQ

Su Consulta Reciente

LSE
SN.
Smith & Nephew
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados